Early research (Phase 1)Study completedNCT03423030
What this trial is testing
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation
Who this might be right for
TuberculosisTuberculosis, Pulmonary
Innovative Medicines for Tuberculosis 32